verapamil has been researched along with s-nitrosocysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dudman, NP; Fu, WY; Perry, MA; Wang, XL | 1 |
| Bates, JN; Bhopatkar, MY; Lewis, SJ; Walton, TM | 1 |
2 other study(ies) available for verapamil and s-nitrosocysteine
| Article | Year |
|---|---|
Homocysteine attenuates hemodynamic responses to nitric oxide in vivo.
Topics: Acetylcholine; Animals; Arterioles; Blood Pressure; Calcium Channel Blockers; Cysteine; Dose-Response Relationship, Drug; Drug Interactions; Femoral Artery; Homocysteine; Male; Nicardipine; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Regional Blood Flow; S-Nitrosothiols; Vasodilator Agents; Verapamil | 2002 |
Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cysteine; Diltiazem; Hindlimb; Hydrazines; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Rats; Rats, Inbred SHR; Rats, Inbred WKY; S-Nitrosothiols; Vascular Resistance; Vasodilation; Vasodilator Agents; Verapamil | 2005 |